NovaBridge Biosciences - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NBP Nasdaq 2836 www.novabridge.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NovaBridge Biosciences

Is There An Opportunity With NovaBridge Biosciences' (NASDAQ:NBP) 40% Undervaluation? - Jan 8th, 2026 10:13 am
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer - Jan 6th, 2026 5:00 am
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - Dec 30th, 2025 5:00 am
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In Growth - Dec 19th, 2025 4:09 am
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO - Dec 10th, 2025 11:12 pm
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO - Dec 4th, 2025 5:34 am
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward - Nov 20th, 2025 10:46 pm
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries - Oct 30th, 2025 2:15 am